AVTR
Avantor, Inc. NYSE$7.99
Mkt Cap $5.5B
52w Low $7.26
8.4% of range
52w High $15.93
50d MA $8.14
200d MA $11.21
P/E (TTM)
-10.2x
EV/EBITDA
81.8x
P/B
1.0x
Debt/Equity
0.7x
ROE
-9.9%
P/FCF
15.7x
RSI (14)
—
ATR (14)
—
Beta
1.00
50d MA
$8.14
200d MA
$11.21
Avg Volume
10.6M
About
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customiz…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 0.16 | 0.17 | +6.2% | 7.85 | +0.1% | +3.2% | +1.4% | — | — | — | — | — |
| Feb 11, 2026 | TNS | 0.21 | 0.22 | +4.8% | 9.64 | -1.5% | -5.2% | -4.6% | -6.1% | -3.8% | -4.5% | -17.7% | — |
| Oct 29, 2025 | TNS | 0.22 | 0.22 | -2.1% | 11.58 | -2.2% | -4.6% | +2.1% | +0.9% | +0.0% | +0.0% | +1.3% | — |
| Aug 1, 2025 | TNS | 0.25 | 0.24 | -4.0% | 11.36 | +0.4% | -0.5% | +2.5% | -1.6% | +0.2% | +1.2% | +17.0% | — |
| Apr 25, 2025 | TNS | 0.23 | 0.23 | -0.6% | 12.93 | -0.1% | -3.4% | -1.9% | +0.5% | +0.2% | -0.5% | +1.7% | — |
| Feb 7, 2025 | TNS | 0.25 | 0.27 | +8.0% | 19.16 | +1.8% | -0.8% | -4.0% | -5.8% | -5.5% | -6.7% | -9.8% | — |
| Oct 25, 2024 | TNS | 0.25 | 0.26 | +2.1% | 22.43 | +1.5% | +0.9% | +0.4% | +0.1% | -0.3% | -0.5% | -5.9% | — |
| Jul 26, 2024 | TNS | 0.23 | 0.25 | +7.6% | 25.60 | -0.2% | +2.5% | +8.0% | +4.5% | +3.5% | +0.0% | -0.9% | — |
| Apr 26, 2024 | TNS | 0.20 | 0.22 | +9.5% | 23.94 | -0.4% | +0.6% | +1.2% | +2.0% | +1.6% | +3.3% | -1.0% | — |
| Feb 14, 2024 | TNS | 0.22 | 0.25 | +13.6% | 24.40 | +0.0% | -1.4% | -2.6% | -1.4% | +0.0% | +0.8% | +2.8% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Evercore ISI | Maintains | In Line → In Line | — | $7.85 | $7.86 | +0.1% | +3.2% | +1.4% | — | — | — |
| Apr 30 | Citigroup | Maintains | Neutral → Neutral | — | $7.85 | $7.86 | +0.1% | +3.2% | +1.4% | — | — | — |
| Apr 15 | Barclays | Maintains | Underweight → Underweight | — | $8.20 | $8.28 | +1.0% | +2.1% | +0.7% | +3.9% | +3.7% | +4.0% |
| Apr 6 | Evercore ISI | Maintains | In Line → In Line | — | $7.90 | $7.78 | -1.5% | +1.0% | +1.3% | +1.3% | +0.3% | +0.0% |
| Mar 6 | Barclays | Downgrade | Equal Weight → Underweight | — | $8.52 | $8.26 | -3.1% | -4.1% | -4.3% | -4.3% | -2.7% | -7.3% |
| Feb 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.14 | $9.52 | +4.2% | +0.7% | -1.0% | +1.4% | +0.8% | -1.2% |
| Feb 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $9.64 | $9.50 | -1.5% | -5.2% | -4.6% | -6.1% | -3.8% | -4.5% |
| Feb 12 | Citigroup | Maintains | Neutral → Neutral | — | $9.64 | $9.50 | -1.5% | -5.2% | -4.6% | -6.1% | -3.8% | -4.5% |
| Jan 7 | TD Cowen | Maintains | Hold → Hold | — | $12.27 | $12.25 | -0.2% | -1.5% | -1.7% | +1.1% | +0.1% | +2.7% |
| Jan 5 | Evercore ISI | Downgrade | Outperform → In Line | — | $11.46 | $11.28 | -1.6% | +3.8% | +7.1% | +5.4% | +5.2% | +8.3% |
Recent Filings
8-K
Avantor, Inc. -- 8-K Filing
Avantor maintained its full-year 2026 guidance despite generating $25 million in cash flow during Q1, suggesting management confidence in operational performance amid ongoing execution.
Apr 29
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appointed Ludovic Brellier as Executive Vice President, expanding its leadership team to strengthen operational oversight and strategic execution.
Apr 23
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new CFO with GE and industrial manufacturing experience joins Avatars, potentially signaling improved financial controls and credibility with investors in capital-intensive operations.
Apr 1
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appointed Sanjeev Mehra as a director effective December 4, 2025, expanding its board composition and potentially bringing new expertise to the life sciences services company's governance.
Feb 25
8-K · 5.02
!!! Very High
Avantor, Inc. -- 8-K 5.02: Executive Change
Avantor appoints Simon Dingemans as director effective January 2, 2026, potentially strengthening board oversight of the life sciences and materials supplier.
Feb 25
8-K · 7.01
! Medium
Avantor, Inc. -- 8-K 7.01: Regulation FD Disclosure
Avantor issued a press release on February 11, 2026, disclosing material information to investors under Regulation FD requirements.
Feb 11
Data updated apr 24, 2026 8:04pm
· Source: massive.com